19:41 , Jun 2, 2017 |  BioCentury  |  Product Development

Ears wide open

Based on unmet need alone, hearing loss should have been every bit as attractive to investors and drug developers as ophthalmic diseases, which entered a renaissance in the mid-2000s resulting in a multibillion-dollar market for...
07:00 , Sep 14, 2015 |  BC Week In Review  |  Financial News

Audion Therapeutics completes venture financing

Audion Therapeutics B.V. , Amsterdam, the Netherlands   Business: Drug delivery, Other   Date completed: 2015-09-07   Type: Venture financing   Raised: EUR2.5 million ($2.8 million)   Investor: INKEF Capital   Note: Audion also received...
08:00 , Feb 17, 2014 |  BC Week In Review  |  Financial News

Audion Therapeutics completes venture financing

Audion Therapeutics B.V. , Amsterdam, the Netherlands   Business: Drug delivery, Other   Date completed: 2/10/14   Type: Venture financing   Raised: Not disclosed   Investor: Eli Lilly and Co.  ...
08:00 , Feb 17, 2014 |  BC Week In Review  |  Company News

Audion Therapeutics, Eli Lilly deal

Hearing loss company Audion received exclusive rights to undisclosed compounds from Eli Lilly in development to treat hearing loss via hair cell regeneration. Under the deal, Lilly has an option to reacquire the compounds after...
08:00 , Feb 17, 2014 |  BC Week In Review  |  Company News

Audion Therapeutics board of directors update

Audion Therapeutics B.V. , Amsterdam, the Netherlands   Business: Drug delivery, Other   Appointed: Shaun Hawkins, VP of Lilly New Ventures  ...
02:21 , Feb 11, 2014 |  BC Extra  |  Financial News

Audion raises series A from Lilly

Hearing loss company Audion Therapeutics B.V. (Amsterdam, the Netherlands) raised an undisclosed amount in a series A round from Eli Lilly and Co. (NYSE:LLY) and received rights to undisclosed compounds from the pharma in development...
08:00 , Jan 17, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Other

Indication Target/marker/pathway Summary Licensing status Publication and contact information Other Hearing loss g-Secretase; notch 1 (NOTCH1) Studies in cell culture and in rodents suggest blocking NOTCH1 processing using g-secretase inhibitors could help treat hearing loss....
08:00 , Jan 17, 2013 |  BC Innovations  |  Targets & Mechanisms

gamma-Secretase lost and sound

Researchers in Boston and Japan have devised a pharmacological method to transform inner ear epithelial cells into working hair cells and have used the method to restore hearing in deaf mice. 1 The finding provides...
07:00 , Jun 20, 2011 |  BC Week In Review  |  Company News

Audion Therapeutics, Sanofi deal

Sanofi partnered with Audion Therapeutics to discover and develop small molecule therapeutics to treat hearing loss. The therapeutics will target endogenous progenitor cells in the inner ear to stimulate their differentiation into auditory sensory hair...
00:31 , Jun 17, 2011 |  BC Extra  |  Company News

Sanofi, Audion in hearing loss partnership

Sanofi (Euronext:SAN, NYSE:SNY) partnered with Audion Therapeutics BV (Amsterdam, the Netherlands) to discover and develop small molecule therapeutics to treat hearing loss. The therapeutics will target endogenous progenitor cells in the inner ear to stimulate...